EMJ Podcast: Insights For Healthcare Professionals

Join us for the latest EMJ Podcast episode about PBC, in which leading experts in the field discuss the newest developments and regulatory challenges in advancing treatment. David Jones, Newcastle University, UK; and Gideon Hirschfield, Toronto General Hospital, Ontario, Canada, address the impacts of treatment on patient quality of life, as well as the difficulties of collecting long-term data.

How can hypnosis be introduced in clinical practice? Find out with Sarah Partridge, Consultant in Clinical Oncology at Imperial Healthcare NHS Trust, London. In this second instalment, Jonathan and Sarah discuss success stories of hypnosis in a medical setting, and the potential benefits it provides to patient care.

Use the following timestamps to navigate the episode:

(00:00)-Introduction 

(01:00)-Sarah’s approach to communicating hypnosis to patients

(06:22)-Success story of hypnosis

(08:12)-Clinical trials testing hypnosis in clinical practice

(16:30)-Sarah’s three magical wishesEpisode 204: Hypnosis: A Magical Tool in Clinical Scenarios – Part 2

Could clinical hypnosis improve outcomes for patients? Find out with Sarah Partridge, Consultant in Clinical Oncology at Imperial Healthcare NHS Trust, London. In this episode, Jonathan and Partridge discuss how hypnosis can be harnessed in a clinical setting, how it can be normalised, and its impact managing side effects.

Use the following timestamps to navigate our episode!

(00:00)-Introduction

(01:45)-Sarah’s route to clinical oncology

(04:22)-Discovering and implementing hypnosis as a tool

(08:12)-Hypnosis in managing side effects

(12:18)-Hypnosis in clinical scenarios

(16:31)-Tranceform: The era of digital resources

(21:00)-Normalising clinical hypnosis

(24:51)-Hypnosis: A different form of dissociative state

This podcast explores health psychology in gastroenterology. Jonathan and Megan Riehl, University of Michigan, Ann Arbor, USA, discuss brain-gut behavioural therapies, misconceptions surrounding mental health and gastrointestinal conditions, and her book "Mind Your Gut".

Timestamps:

(00:00)-Introduction

(03:28)-Megan’s journal to health psychology

(6:30)-Lifestyle factors and digestive distress

(10:45)-Brain-gut behavioural therapies

(17:00)-Common misconceptions in IBS

(21:34)-The microbiome: feeding your gut

(25:20)-Integrating GI mental health into practice

(29:45)- 'Mind Your Gut'

(35:06)-‘The Gut Health Podcast’

(38:40)-Megan’s three wishes for healthcare

Nick Oliver, Wynn Professor of Human Metabolism at Imperial College Healthcare NHS Trust, London, UK, joins Jonathan to discuss all things diabetes, from patient education to awareness for diabetes prevention, as well as research into islet cell transplantation.

Use the following timestamps to navigate our episode!

(00:00)-Introduction

(02:25)-Nick Oliver, playwright

(05:07)-Nick’s ‘origin story’

(07:33)-Acknowledging the current challenges in diabetes treatment, and goals for the future

(11:00)-Patient awareness and education in the treatment and management of diabetes

(15:29)-Technology in aiding diabetes treatment

(19:03)-Quality of life in real-time continuous glucose monitoring in children

(21:49)-The artificial pancreas: where is it now, and where is it going?

(26:12)-Intraocular islet cell transplantation in early-onset diabetic retinopathy

(29:54)-Innovative developments on the horizon

(33:07)-Research on increased glycaemic variability in pregnant females with gastric bypass

(35:43)-The work of the European Association for the Study of Diabetes (EASD)

(37:16)-Three wishes for the future of healthcare

This episode focuses on monogenic diabetes, diabetes research, and inspiring the next generation of nurses. Jonathan is joined by Maggie Shepherd, Honorary Clinical Professor at the University of Exeter Medical School, UK. The pair explore how we can strengthen the research influence of nurses, including the 70@70 programme, as well as Shepherd’s initiatives to encourage a career in nursing and research in nursing.

Use the following timestamps to navigate our episode!

(00:00)-Introduction  (03:43)-Entering into diabetes research (04:27)-Monogenic diabetes  (07:01)-70@70 initiative  (11:00)-Aster Guardians Global Nursing award (12.32)-Successes, challenges, and opportunities in monogenic diabetes (14:48)-Patient care during COVID-19  (17:30)-‘1 in 6 Billion’ podcast (19:56)-Inspiring the next generation (23:09)-Maggie’s wishes for the future of healthcare 

CoMiSS, the “Cow’s Milk related Symptom Score”,  is a valuable resource for healthcare professionals, parents, and carers alike, offering an easy-to-use awareness tool that supports the recognition of cow’s milk-related symptoms in infants and young children.

2024 marks the 10th anniversary of CoMiSS, prompting us to look back at the decade of science and clinical practice behind the tool. The podcast reflects on the tool’s inception, its impact on aiding earlier diagnosis, and its role in evaluating therapeutic interventions for managing symptoms of cow’s milk allergy (CMA).

This podcast episode dives into the screening and management of Duchenne muscular dystrophy, as well as diversity in genetic databases, and treating neuromuscular disorders. Jonathan is joined by Madhuri Hegde, Senior Vice-President & Chief Scientific Officer at Revvity, Inc., to talk about innovation in genomic testing.

Use the following timestamps to navigate our episode!

(00:00)-Introduction 

(03:54)-Entering into genomic technologies

(05:13)-Duchenne muscular dystrophy

(10:47)-Revvity and genome sequencing

(13:13)-Ultrarapid genomic testing (urWGS)

(15:18)-LANTERN project

(17:42)-Lack of diversity in genetic databases

(20:06)-New developments in genetics

(22:19)-COVID-19 testing laboratories

(27:27)-Madhuri’s wishes for healthcare

This podcast provides insights on the diagnosis of sJIA (systemic juvenile idiopathic arthritis) and its treatment from real-world experience within Great Ormand Street Hospital (GOSH).

This is a promotional podcast, funded by Sobi and organised in conjunction with EMJ for healthcare professionals in Great Britain, Northern Ireland, and Ireland only. Elements of this podcast will contain promotional content for Kineret®️ (anakinra).

Prescribing information can be found at:

Jonathan is joined by Joshua Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign, Stanford University, California, USA. The pair navigate fascinating themes, from Makower’s passion for music and his band, Still Trust, to innovative strategies for controlling rising healthcare costs through innovation. Makower offers perspectives on AI in healthcare, and the associated challenges with regulating these new technologies.

Use the following timestamps to navigate the topics discussed in this episode:

(00:00)-Introduction 

(03:05)-A passion for music 

(06:11)-From the Massachusetts Institute of Technology (MIT) to medical school 

(08:50)-The Biodesign process 

(19:37)-Driving technology from mind to marketplace 

(23:25)-Doctors engaging with industry 

(27:52)-The ExploraMed incubator 

(31:07)-Josh’s current work 

(34:27)-The importance of failure 

(36:16)-Perspectives on artificial intelligence in healthcare 

(39:05)-Healthcare innovation horizons 

(40:37)-Medical technology regulation 

(46:00)-Josh’s three wishes for the future of healthcare